x
Search
News Center
> News Center
  • NEWS
    Virogenbio’s VG712 Approved by FDA to Initiate Clinical Trial for aGvHD Indication
    July 03,2025
  • NEWS
    Virogenbio’s VG712 Approved by FDA to Initiate Clinical Trial for a Second Indication
    March 29,2025
  • NEWS
    Virogenbio’s VG712 Approved by FDA to Initiate Pivotal Phase II Clinical Trial
    October 22,2024
  • NEWS
    Moffitt Cancer Center and Virogen Biotechnology Forge Groundbreaking Partnership to Accelerate Oncology and Immunotherapy Innovations
    May 31,2024